- Free from Publisher L Meyer, P Bohme, I Delbachian, P Lehert, N … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Treatment with metformin was associated with a reduction in daily
insulin requirements between V0 and V6 of −4.3 ± 9.9 units (−7.8 ± 18%)
compared with an increase with placebo treatment of 1.7 ± 8.3 units (2.8 ... Cited by 19 - Related articles - BL Direct - All 5 versions
AS Khan, CR McLoughney, AB Ahmed - DIABETIC MEDICINE-CHICHESTER-, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 14 - Related articles - BL Direct - All 5 versions
- ►eje.org [PDF] S Sarnblad, M Kroon, J Aman - European Journal of Endocrinology, 2003 - eje.org Objective: Metabolic control often deteriorates during puberty in children with
type 1 diabetes. The aim of the present study was to investigate whether
addition of metformin for 3 months improves metabolic control and insulin ... Cited by 34 - Related articles - BL Direct - All 7 versions
RJ Moon, LA Bascombe, RI Holt - Diabetes Obes Metab, 2007 - interscience.wiley.com Materials and Methods: A 3-month prospective open-labelled pilot study of 16
patients aged 18-40 with T1DM and body mass index (BMI) >25 kg/m 2 was
performed. The patients received 500-850 mg metformin twice daily. Insulin ... Cited by 12 - Related articles - All 4 versions
- ►diabetesjournals.org [PDF] JD Faichney, PW Tate - Diabetes care, 2003 - Am Diabetes Assoc Our objective was to evaluate the di- agnostic proficiency of the World Health
Organization (WHO) and the National Cholesterol Education Pro- gram (NCEP)-III
definitions (1,2) for the metabolic syndrome in a Mexican nation- wide, ... Cited by 4 - Related articles - BL Direct - All 5 versions
S Lacigova, Z Rusavý, Z Jankovec, P … - Casopís lékar̆ů c̆eských, 2001 - ncbi.nlm.nih.gov BACKGROUND: Metformin is popular for it's complex mechanism of action in
treatment of the type 2. diabetes. The effect in type 1. diabetes is studied
less frequently. The aim of our open, prospective, placebo controlled study ... Cited by 5 - Related articles
- ►diabetesjournals.org J Hamilton, E Cummings, V Zdravkovic, D … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—At t = 0, HbA 1c was 9.2 ± 0.9%, insulin dosage was 1.2 ± 0.2 units
· kg − 1 · day − 1 , fasting glucose was 10.6 ± 2.4 mmol/l, and BMI was
24.2 ± 3.9 kg/m 2 (means ± SD), with no difference between the metformin ... Cited by 70 - Related articles - BL Direct - All 6 versions
G Pagano, V Tagliaferro, Q Carta, MT Caselle, … - Diabetologia, 1983 - Springer Summary. The effect of metformin on Type 1 (insulin-depend- ent) diabetes has
been assessed with the artificial pancreas. Fourteen Type I diabetic patients of
normal body weight re- ceived in addition to their usual insulin therapy ... Cited by 38 - Related articles - All 2 versions
AW Ferguson, PL De La Harpe, JW Farquhar - Lancet, 1961 - ncbi.nlm.nih.gov 1: Lancet. 1961 Jun 24;1(7191):1367-9. Dimethyldiguanide in the treatment of
diabetic children. FERGUSON AW, DE LA HARPE PL, FARQUHAR JW. ... Cited by 9 - Related articles
V Zdravkovic, JK Hamilton, D Daneman, EA … - The Journal of pediatrics, 2006 - Elsevier Metabolic control (A1c) was improved at 6 months in all subjects (P = .02).
There was no significant difference between the pioglitazone and placebo
treatment groups at 6 months in either change in A1c (−0.4% ± 0.9% and ... Cited by 10 - Related articles - All 3 versions
